Linde plc (LIN) — Company Research
Linde plc (NASDAQ: LIN) is a UK-headquartered, Ireland-incorporated industrial gas company — the world's largest by sales — producing atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (hydrogen, helium, carbon dioxide, electronic and specialty gases), and designing and constructing turnkey process plants (per the FY2025 10-K, Item 1, filed 2026-02-25). For the year ended December 31, 2025 the Company reported revenue of $34.0 billion (+3% year over year), operating income of $9.25 billion (per EDGAR XBRL OperatingIncomeLoss reads $8,923,000,000 from the 10-K; the 10-K Item 7 GAAP figure is $9.254 billion), net income of $6.90 billion and diluted EPS of $14.61 (per the FY2025 10-K, Item 7, filed 2026-02-25); free cash flow was $5.09 billion (per yfinance annual cashflow, FY2025). The Company has approximately $7 billion of sale-of-gas backlog under construction (per the FY2025 10-K, Item 1). The stock last traded at $517.58 against a 52-week range of $387.78 to $521.28 (per yfinance, pulled 2026-05-26); Q1 2026 reported on 2026-05-01 (sales $8.8 billion, +8% YoY; adjusted EPS $4.33, +10%). Linde employed 65,177 people worldwide as of 2025-12-31 (per the FY2025 10-K, Item 1).
1. Company Snapshot
| Field | Value |
|---|---|
| Name | Linde plc (per the FY2025 10-K, cover page, filed 2026-02-25) |
| Ticker / Exchange | LIN / Nasdaq Global Select Market (per the FY2025 10-K, cover page) |
| Sector / Industry | Basic Materials / Specialty Chemicals — Industrial Gases (per yfinance, pulled 2026-05-26; the FY2025 10-K, Item 1) |
| Market cap | $239.3bn (per yfinance, 2026-05-26) |
| Enterprise value | $263.3bn (per yfinance, 2026-05-26) |
| FY2025 revenue | $34.0bn (per the FY2025 10-K, Item 7, filed 2026-02-25) |
| FY2025 operating income (EDGAR XBRL) | $8.92bn (per EDGAR XBRL OperatingIncomeLoss, 10-K period ending 2025-12-31) — the FY2025 10-K Item 7 GAAP figure is $9.25bn (differing on items classification) |
| FY2025 free cash flow | $5.09bn (per yfinance annual cashflow, FY2025) |
| Gross margin (FY2025) | 48.8% (gross profit $16.6bn on revenue $34.0bn, per the FY2025 10-K, Item 7) |
| Net margin (FY2025) | 20.3% (net income $6.90bn on revenue $34.0bn, per the FY2025 10-K, Item 7) |
| Employees | 65,177 worldwide as of 2025-12-31 (approximately 28% women, 72% men, per the FY2025 10-K, Item 1) |
| CEO | Sanjiv Lamba (per the FY2025 10-K) |
| Headquarters | Woking, United Kingdom (principal executive offices); owned office space in Danbury, Connecticut; incorporated in Ireland (per the FY2025 10-K, Item 2 and Item 1) |
| Website | linde.com (per yfinance, pulled 2026-05-26) |
| Fiscal year-end | December 31 (per the FY2025 10-K, filed 2026-02-25) |
| Next earnings | Q2 2026 (Q1 2026 reported 2026-05-01 per Linde IR; the next report date is not disclosed in this report's source data) |
| Dividend yield | 1.24% — annual dividend rate $6.40, raised 7% in early 2026 (33 consecutive years of dividend increases, per Linde Q1 2026 release 2026-05-01) |
| 52-week high | $521.28 (per yfinance, pulled 2026-05-26) |
| 52-week low | $387.78 (per yfinance, pulled 2026-05-26) |
| Short interest | 1.33% of float (per yfinance shortPercentOfFloat, pulled 2026-05-26) |
2. Bull Case vs Bear Case
Bull Case
- Consistent earnings growth in a defensive end market. Per the FY2025 10-K (Item 7, filed 2026-02-25): FY2025 diluted EPS was $14.61, up from $13.62 (FY2024), $12.59 (FY2023) and $8.23 (FY2022) — a 21% CAGR over three years. Per the Q1 2026 release (2026-05-01): adjusted EPS rose 10% to $4.33 (5% ex-currency), with operating margin reaching 30%.
- Dividend Aristocrat with 33 consecutive years of increases. Per the Q1 2026 release (2026-05-01): Linde raised its annual dividend by 7% in early 2026, marking 33 consecutive years of increases with an average 13% growth rate. The annual rate is now $6.40 per share (per yfinance, pulled 2026-05-26).
- Backlog and hydrogen / clean-energy exposure. Per the FY2025 10-K (Item 1, filed 2026-02-25): Linde's sale-of-gas backlog of large projects under construction was approximately $7 billion as of FY2025 year-end. The Company highlights hydrogen production and carbon capture as growth platforms within the Chemicals and Energy end market.
- High and improving margins. Per the FY2025 10-K (Item 7, filed 2026-02-25): FY2025 gross margin was 48.8% and net margin 20.3%, with operating margin (yfinance TTM) of 28.5%. Per the Q1 2026 release (2026-05-01): Q1 2026 operating margin reached 30%, up 50 basis points sequentially.
- Active capital return — buybacks plus dividends. Per the FY2025 10-K (cash flow, filed 2026-02-25): FY2025 repurchases were $4.60 billion, bringing FY2022–FY2025 cumulative buybacks to approximately $18.2 billion and reducing shares outstanding from 492.5 million (FY2022) to 463.7 million (FY2025).
Bear Case
- Cyclical exposure to manufacturing, metals and electronics end-markets. Per the FY2025 10-K (Item 1, filed 2026-02-25): customers span healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics — many of which are cyclical and exposed to global industrial activity, foreign exchange and commodity price volatility.
- Mid-30s trailing P/E versus mid-single-digit revenue growth. Per yfinance (pulled 2026-05-26): trailing P/E is 34.4, forward P/E is 26.3 and EV/EBITDA is 19.4 against FY2025 revenue growth of +3% — the equity already prices in a continuation of the earnings compounding rather than a meaningful re-acceleration.
- Total debt at $26.3 billion and rising. Per the FY2025 10-K (balance sheet, filed 2026-02-25) and yfinance: total debt rose from $18.8 billion (FY2022) to $28.1 billion (FY2025) as the Company funded its buyback / capex programme partly with debt; current ratio is 0.83 (per yfinance, pulled 2026-05-26).
- Underlying organic growth was just 3% in Q1 2026. Per the Q1 2026 release (2026-05-01): underlying sales were up 3% (2% pricing + 1% volume); reported sales growth was boosted by a 5% currency tailwind and 1% from acquisitions — meaning the durability of mid-to-high single-digit revenue growth depends on FX trends.
- Foreign exchange and geopolitical exposure. Per the FY2025 10-K (Item 1A, filed 2026-02-25): Linde operates in the United States, Brazil, Mexico, Canada, Germany, the United Kingdom, Eastern Europe, China, Australia, South Korea and India, with revenue translation and customer demand exposed to currency moves and country-specific risk.
3. What Does Linde Actually Do?
Linde reports as an integrated industrial gas business with engineering-services capability (per the FY2025 10-K, Item 1, filed 2026-02-25). Segment-level revenue breakdown is not separately extracted in this report's source data; the qualitative product / customer breakdown is:
| Service line / product | Description |
|---|---|
| Atmospheric gases | Oxygen, nitrogen, argon and rare gases — produced via air separation units, sold to manufacturing, healthcare, food & beverage, electronics (per the FY2025 10-K, Item 1) |
| Process gases | Hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases and acetylene — sold to chemicals and energy, electronics and metals end-markets (per the FY2025 10-K, Item 1) |
| Engineering — sale of plant | Design and construction of turnkey process plants for third-party customers and for Linde's own gas businesses (air separation, hydrogen, synthesis, olefin, natural gas plants) (per the FY2025 10-K, Item 1) |
In plain English, Linde makes the industrial gases that almost every modern factory, hospital, refinery, semiconductor fab and food-processor needs, and also builds the plants that produce those gases. Its contracts with large industrial customers are typically long-term take-or-pay agreements, which is the structural source of its earnings stability. The Company also has a meaningful exposure to hydrogen production and carbon capture (per the FY2025 10-K, Item 1 and Q1 2026 release, 2026-05-01), giving it leverage to the energy-transition theme.
4. The Business Model
Per the FY2025 10-K (Item 1, filed 2026-02-25): Linde's core business model has two characteristics that distinguish it from a typical specialty chemicals company. First, the bulk of its sales come from take-or-pay supply contracts with large industrial customers, often 10–20 years in length, where Linde finances and operates an on-site air separation or hydrogen unit dedicated to that customer; the customer commits to minimum take volumes regardless of actual utilisation. Second, the Engineering business sells turnkey plants both to third parties and to Linde's own gas businesses — providing in-house capability to win large industrial projects and a structural cost advantage on internal capex.
Per the Q1 2026 release (2026-05-01) and the FY2025 10-K (Item 7): the pricing mechanism is largely pass-through (electricity, natural gas, freight) plus inflation-linked escalators, which is why Q1 2026 underlying growth of 3% comprised 2% pricing and only 1% volume — pricing is consistently positive across cycles. The Company also has an active capital-recycling programme, returning $4.60 billion via buybacks and a 7% dividend increase in FY2025 (per the FY2025 10-K, cash flow and the Q1 2026 release).
5. Financial Health
5-year income trend (per the FY2025 10-K Item 7 and yfinance annual financials; FY2021 not in source data):
| FY | Revenue | Operating income | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|---|
| FY2025 | $34.0bn | $9.25bn (10-K Item 7; EDGAR XBRL $8.92bn) | $6.90bn | $14.61 | $5.09bn |
| FY2024 | $33.0bn | $8.60bn | $6.57bn | $13.62 | $4.93bn |
| FY2023 | $32.9bn | $8.11bn | $6.20bn | $12.59 | $5.52bn |
| FY2022 | $33.4bn | $6.46bn | $4.15bn | $8.23 | $5.69bn |
| FY2021 | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data |
Per the FY2025 10-K (Item 7, filed 2026-02-25): FY2025 revenue grew 3% on 2% pricing and modest volume; operating income expanded faster (+8% YoY) driven by pricing leverage and operating-efficiency programmes. EPS growth has compounded faster than revenue because of share-count reduction via the buyback programme.
Balance sheet (per the FY2025 10-K, balance sheet, filed 2026-02-25):
| FY | Cash & equivalents | Total debt | Stockholders' equity | Shares outstanding | Buybacks |
|---|---|---|---|---|---|
| FY2025 | $5.06bn | $28.07bn | $38.25bn | 463.7M | $4.60bn |
| FY2024 | $4.85bn | $22.61bn | $38.09bn | 473.2M | $4.48bn |
| FY2023 | $4.66bn | $20.32bn | $39.72bn | 482.4M | $3.96bn |
| FY2022 | $5.44bn | $18.79bn | $40.03bn | 492.5M | $5.17bn |
Quarterly trend, last 5 quarters (per yfinance quarterly financials; figures are GAAP):
| Quarter | Revenue | Gross profit | Operating income (GAAP) | Net income | Diluted EPS (GAAP) |
|---|---|---|---|---|---|
| Q1 2026 (2026-03-31) | $8.78bn | $4.26bn | $2.38bn (adjusted $2.6bn, op margin 30%, per Q1 2026 release 2026-05-01) | $1.86bn | $3.98 (adjusted $4.33) |
| Q4 2025 (2025-12-31) | $8.76bn | $4.22bn | $2.35bn | $1.53bn | $3.26 |
| Q3 2025 (2025-09-30) | $8.62bn | $4.24bn | $2.34bn | $1.93bn | $4.09 |
| Q2 2025 (2025-06-30) | $8.50bn | $4.19bn | $2.34bn | $1.77bn | $3.73 |
| Q1 2025 (2025-03-31) | $8.11bn | $3.96bn | $2.22bn | $1.67bn | $3.51 |
6. Valuation & Market Data
Raw market data only — no commentary on cheap or expensive.
| Metric | Value |
|---|---|
| Share price | $517.58 (per yfinance, pulled 2026-05-26) |
| Previous close | $514.51 (per yfinance, pulled 2026-05-26) |
| Day range | $514.98 – $521.23 (per yfinance, pulled 2026-05-26) |
| 52-week high / low | $521.28 / $387.78 (per yfinance, pulled 2026-05-26) |
| Market cap | $239.3bn (per yfinance, pulled 2026-05-26) |
| Enterprise value | $263.3bn (per yfinance, pulled 2026-05-26) |
| Shares outstanding | 462.3M (per yfinance, pulled 2026-05-26; 463.7M reported at 2025-12-31 in the FY2025 10-K) |
| Float | 461.0M (per yfinance, pulled 2026-05-26) |
| Avg daily volume (10d) | 1.88M (per yfinance averageVolume10days, pulled 2026-05-26) |
| Volume (latest) | 1.45M (per yfinance, pulled 2026-05-26) |
| Beta | 0.74 (per yfinance, pulled 2026-05-26) |
| Trailing P/E (GAAP) | 34.37 (per yfinance, pulled 2026-05-26) |
| Forward P/E | 26.26 (per yfinance, pulled 2026-05-26) |
| P/S (TTM) | 6.91 (per yfinance, pulled 2026-05-26) |
| P/B | 6.21 (per yfinance, pulled 2026-05-26) |
| EV / Revenue (TTM) | 7.60 (per yfinance, pulled 2026-05-26) |
| EV / EBITDA | 19.38 (per yfinance, pulled 2026-05-26) |
| P / FCF | not disclosed in this report's source data (per yfinance, pulled 2026-05-26) |
| Gross margin (TTM) | 48.77% (per yfinance, pulled 2026-05-26) |
| Operating margin (TTM GAAP) | 28.47% (per yfinance, pulled 2026-05-26) |
| Net margin (TTM) | 20.44% (per yfinance, pulled 2026-05-26) |
| ROE | 18.23% (per yfinance, pulled 2026-05-26) |
| ROA | 7.24% (per yfinance, pulled 2026-05-26) |
| Debt-to-equity | 65.64 (per yfinance, pulled 2026-05-26) |
| Current ratio | 0.83 (per yfinance, pulled 2026-05-26) |
| Dividend yield | 1.24% (annual rate $6.40, per yfinance, pulled 2026-05-26) |
| Short interest | 1.33% of float (per yfinance shortPercentOfFloat, pulled 2026-05-26) |
| Put / call ratio | not disclosed in this report's source data |
7. What Are They Building / What's Coming
Per the FY2025 10-K (Item 1, filed 2026-02-25), the Q1 2026 release (2026-05-01) and named public announcements:
- $7 billion sale-of-gas project backlog. Per the FY2025 10-K (Item 1, filed 2026-02-25): Linde reported approximately $7 billion of sale-of-gas backlog under construction at FY2025 year-end, representing future revenue contracted but not yet delivered.
- Hydrogen and carbon capture growth platforms. Per the FY2025 10-K (Item 1, filed 2026-02-25) and the Q1 2026 release (2026-05-01): Linde's gases and process technologies enable clean hydrogen production and carbon capture, with Americas growth in Q1 2026 partly driven by higher activity in hydrogen and nitrogen in U.S. Gulf Coast refining.
- Electronics gases expansion. Per the FY2025 10-K (Item 1, filed 2026-02-25): electronics is a structurally growing end-market for specialty gases, driven by semiconductor fab capacity additions in the US, China, South Korea and Taiwan.
- Capex programme of ~$5.3 billion in FY2025. Per the FY2025 10-K (cash flow, filed 2026-02-25): capital expenditure was $5.26 billion in FY2025, predominantly on long-life on-site air-separation and hydrogen capacity tied to take-or-pay contracts.
8. Competitive Landscape
Linde competes globally in industrial gases against Air Liquide (Euronext: AI), Air Products & Chemicals (NYSE: APD) and a number of regional players (per the FY2025 10-K, Item 1, filed 2026-02-25). Peer comparison (per yfinance, pulled 2026-05-26; all figures in USD except Air Liquide which is in EUR).
| Company | Ticker | Market cap | Revenue (TTM) | Gross margin | P/S |
|---|---|---|---|---|---|
| Linde plc | LIN | $239.3bn | $34.65bn | 48.77% | 6.91 |
| Air Products & Chemicals, Inc. | APD | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data |
| Air Liquide S.A. | AI.PA | not disclosed in this report's source data — Euronext-listed | not disclosed in this report's source data | not disclosed in this report's source data | not disclosed in this report's source data |
The peer market-data row entries for APD and Air Liquide are not in this report's source data — at publish time the pipeline did not pull yfinance data for those tickers; the named competitive set is drawn from the FY2025 10-K (Item 1). Linde's competitive positioning rests on global scale (#1 by sales), long-term take-or-pay supply contracts, and integrated engineering capability.
9. Leadership and Ownership
Per the FY2025 10-K (Item 1, filed 2026-02-25): Sanjiv Lamba is Chief Executive Officer of Linde plc. Detailed executive tenure and proxy-level biographical information beyond the senior-leadership roles is not disclosed in this report's source data (the Item 10 proxy section was not in the extracted 10-K text).
Top institutional shareholders as of 2026-03-31 (per yfinance institutional_holders, pulled 2026-05-26):
| Holder | % held | Shares | Value (USD) |
|---|---|---|---|
| BlackRock Inc. | 7.60% | 36,872,272 | $19.08bn |
| Vanguard Capital Management LLC | 6.24% | 30,233,070 | $15.65bn |
| State Street Corporation | 4.05% | 19,625,129 | $10.16bn |
| Capital Research Global Investors | 3.31% | 16,051,934 | $8.31bn |
| Vanguard Portfolio Management LLC | 2.53% | 12,289,282 | $6.36bn |
| Geode Capital Management, LLC | 2.44% | 11,832,240 | $6.12bn |
| T. Rowe Price Associates Inc | 2.03% | 9,846,511 | $5.10bn |
| FMR, LLC (Fidelity) | 1.86% | 8,997,328 | $4.66bn |
| Morgan Stanley | 1.52% | 7,358,093 | $3.81bn |
| JPMorgan Chase & Co | 1.29% | 6,255,468 | $3.24bn |
Per yfinance (pulled 2026-05-26): institutional ownership totals 89.36% and insider ownership totals 0.25% — typical for a mega-cap S&P 500 industrial.
10. Risks and Challenges
- Cyclical industrial end-market exposure (Market & Demand): Per the FY2025 10-K (Item 1A, filed 2026-02-25): Linde's customers span manufacturing, metals and mining, chemicals and electronics, each exposed to global industrial activity cycles, commodity prices and end-market demand swings.
- Foreign exchange and geopolitical exposure (Market & Demand): Per the FY2025 10-K (Item 1A, filed 2026-02-25): the Company operates in the United States, Brazil, Mexico, Canada, Germany, the United Kingdom, Eastern Europe, China, Australia, South Korea and India — with revenue translation, customer demand and asset values exposed to currency moves and country-specific political and regulatory risk.
- Energy and feedstock cost pass-through risk (Operational): Per the FY2025 10-K (Item 1A, filed 2026-02-25): the production and distribution of industrial gases is energy-intensive; rising or volatile electricity and natural-gas prices can compress margins in the gap before pass-through pricing fully adjusts.
- Engineering / sale-of-plant project risk (Operational): Per the FY2025 10-K (Item 1, filed 2026-02-25): "the construction and sale of plants by Linde may give rise to risks associated with the production, filling, storage, handling and transportation" of gases — cost-overruns, schedule delays and operational incidents on large projects are recurring exposures.
- Indebtedness and rising leverage (Financial): Per the FY2025 10-K (balance sheet, filed 2026-02-25): total debt rose from $18.8 billion (FY2022) to $28.1 billion (FY2025) to fund the buyback / capex programme; current ratio is 0.83 (per yfinance, pulled 2026-05-26), and any sharp tightening in credit conditions could constrain capital-return flexibility.
- Regulatory and environmental compliance (Regulatory): Per the FY2025 10-K (Item 1A, filed 2026-02-25): Linde is subject to environmental, safety and product-stewardship regulation in every jurisdiction in which it operates, with ongoing compliance and remediation cost exposure.
- Cybersecurity incidents (Cyber & Physical): Per the FY2025 10-K (Item 1C and Item 1A, filed 2026-02-25): cyber incidents at Linde or at its key on-site customers could disrupt gas supply, customer billing or proprietary engineering data, with material adverse effect potential.
- Competition from large incumbents and consolidating regionals (Competitive): Per the FY2025 10-K (Item 1, filed 2026-02-25): Linde competes globally with Air Liquide and Air Products & Chemicals, plus regional players in specific geographies and end-markets — pricing discipline and contract renewal terms are recurring competitive flashpoints.
11. Recent Developments
Most recent first.
- 2026-05-01 — Q1 2026 results: adjusted EPS $4.33 (+10%), 7% dividend increase (33 consecutive years): Sales were $8.8 billion (+8% YoY; underlying +3%); operating profit $2.6 billion at a 30% adjusted operating margin (+50 bps sequentially); operating cash flow $2.2 billion; free cash flow $0.9 billion after $1.3 billion capex. Source: Linde Q1 2026 release, 2026-05-01.
- 2026-04-07 — Linde announces Q1 2026 earnings and conference-call schedule: Confirmed the May 1, 2026 release date and webcast schedule. Source: Linde / Business Wire, 2026-04-07.
Linde's official X (Twitter) handle is @Linde. No additional independently link-verifiable X items within the 30-day window are included in this report's source data.
12. Key Dates Coming Up
- Q2 2026 earnings — date not disclosed in this report's source data: Q1 2026 was reported on 2026-05-01; Linde typically reports Q2 in early August.
- 2026 Annual General Meeting: Per the FY2025 10-K (filed 2026-02-25): the 2026 AGM proxy materials are to be filed with the SEC within 120 days after fiscal year-end (i.e. by approximately late April 2026); the specific meeting date is not disclosed in this report's source data.
- Next dividend payment date — not disclosed in this report's source data: The annual dividend rate is $6.40 per share following the 7% increase announced in early 2026 (per Linde Q1 2026 release, 2026-05-01).
- Sale-of-gas backlog conversion: Per the FY2025 10-K (Item 1, filed 2026-02-25): approximately $7 billion of sale-of-gas backlog is under construction at FY2025 year-end and will convert to revenue across the multi-year build / start-up schedule; specific timing is not disclosed in this report's source data.
Risk Warning: This research is for information only and is not investment advice or a recommendation to buy or sell any security. CFD Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74–89% of retail investor accounts lose money when trading CFDs. Affiliate Disclosure: We may receive a commission from some links on this page at no extra cost to you. Data Disclaimer: All figures are sourced from company filings, earnings releases, and public market data as at the date above. Forward-looking statements are attributed to the company and may not be achieved. Always do your own research. Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice.
Loading research report…
13. Thesis Verdict
The central thesis. Linde plc (NASDAQ: LIN) is the world’s largest industrial gas company by sales, generating high-margin recurring revenue from long-term take-or-pay supply contracts across atmospheric and process gases, augmented by an in-house Engineering business. Per the FY2025 10-K (Item 7, filed 25 February 2026): FY2025 revenue was $34.0bn (+3% YoY), operating income $9.25bn, net income $6.90bn and diluted EPS $14.61. Per the Q1 2026 release (1 May 2026): adjusted EPS $4.33 (+10%), operating margin 30%, dividend raised 7% (33 consecutive years of increases).
What would confirm or break it. Confirmation comes from continued mid-to-high single-digit reported sales growth, conversion of the $7bn sale-of-gas backlog, and operating-margin expansion driven by pricing leverage and hydrogen / electronics-gas exposure. Risks: a step-down in underlying organic growth (Q1 2026 underlying was only +3%), unfavourable foreign-exchange reversal (Q1 2026 reported growth had a 5pt FX tailwind), or cost-overruns on large turnkey plant projects in the Engineering business.
Watchpoints
- ConfirmsMid-to-high single-digit reported sales growth combined with operating-margin expansion (Q1 2026 adjusted op margin 30%, per Linde Q1 2026 release, 1 May 2026).
- ConfirmsConversion of the $7bn sale-of-gas backlog into revenue across the FY2026–FY2028 schedule (per the FY2025 10-K, Item 1, filed 25 February 2026).
- ConfirmsContinued buyback / dividend discipline (FY2025 buybacks $4.60bn; 33 consecutive years of dividend increases; current annual rate $6.40).
- InvalidatesStep-down in underlying organic growth below the Q1 2026 +3% rate, especially if combined with foreign-exchange reversal (Q1 2026 reported +8% included a 5pt FX tailwind).
- InvalidatesCost-overruns or schedule slippage on large turnkey plant projects in the Engineering business, or a sharp tightening in credit conditions given total debt of $28.1bn (FY2025).
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 26 May 2026.
